Fibromyalgia News

Overlapping fibromyalgia may be present in 30% or more of patients with primary Sjögren’s syndrome based on the American College of Rheumatology 2010 criteria, but only 19% of the same patients met 1990 criteria, according to the results of a study.

The most highly read articles during the month of August on Healio.com/Rheumatology were focused on systemic lupus erythematosus, rheumatoid arthritis and fibromyalgia, among other topics.

Cognitive function was not associated with serum uric acid levels or mean platelet volume in patients with fibromyalgia, according to the details from a recently published study.

Symptoms of fibromyalgia may mimic high disease activity in patients with rheumatoid arthritis, according to recently presented data.

Vitamin D has gained interest within many specialties, as well as in general practice. As such, the results of a number of studies focused on vitamin D in numerous rheumatic diseases were presented at the European League Against Rheumatism, or EULAR, Annual European Congress of Rheumatology.

Patients with fibromyalgia who were deficient in vitamin D were more likely to have higher scores for fatigue and poorer functional scores compared with individuals with fibromyalgia alone or with patients deficient in vitamin D without fibromyalgia, according to findings from a study of patients in Turkey.

Fatigue is a common symptom in nearly every rheumatic disease and can be difficult to address. The impact of fatigue, patient perspective, treatment approaches and assessment were among the topics surrounding fatigue that were presented at the European League Against Rheumatism Annual European Congress of Rheumatology.

Recent analysis shows that individuals with panic and/or anxiety disorders had a higher prevalence of various physical illnesses compared with the general population.

Patients with fibromyalgia may have improvements in fatigue and musculoskeletal pain by increasing vitamin D levels through monthly, intramuscular cholecalciferol injection, according to recently presented research.

A response to treatment with Lyrica in patients with pain from fibromyalgia, diabetic neuropathy, postherpetic neuralgia or spinal cord injury occurred within 3 to 4 weeks on average, according to recently published research.